Chemotherapeutic strategies for renal cell carcinoma

被引：27
|
作者：
Milowsky, MI [1 ]
Nanus, DM [1 ]
机构：
[1] Cornell Univ, Weill Med Coll, Dept Med, Div Hematol Med Oncol, New York, NY 10021 USA
来源：
UROLOGIC CLINICS OF NORTH AMERICA | 2003年 / 30卷 / 03期
关键词：
D O I：
10.1016/S0094-0143(03)00031-4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Metastatic renal cell carcinoma (RCC) is a disease that is highly resistant to systemic chemotherapy Responses to combination chemotherapy have been reported in patients with collecting duct carcinoma and the sarcomatoid variant of renal cancer. Clinical trials combining chemotherapy with biologic response modifiers have not resulted in significant advances in the treatment of RCC. Patients with advanced local or metastatic RCC should be offered investigational therapeutic options. The identification of novel agents with significantly improved antitumor activity remains a high priority in the treatment of this disease.
引用
收藏
页码：601 / +
页数：10
相关论文
共 50 条
  • [41] Synchronous esophageal and renal cell carcinoma: Incidence and possible treatment strategies
    De Hingh, H. J. T.
    Henegouwen, M. I. Van Berge
    Pes, M. P. Laguna
    Busch, O. R. C.
    Van Lanschot, J. B.
    DIGESTIVE SURGERY, 2008, 25 (01) : 27 - 31
  • [42] Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies
    Makhov, Peter
    Joshi, Shreyas
    Ghatalia, Pooja
    Kutikov, Alexander
    Uzzo, Robert G.
    Kolenko, Vladimir M.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (07) : 1355 - 1364
  • [43] When is metastatic renal cell carcinoma not renal cell carcinoma?
    Billings, S.
    Henley, J.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2007, 34 (01) : 99 - 100
  • [44] Antiangiogenic chemotherapeutic agents: Characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models
    Schirner, M
    Hoffmann, J
    Menrad, A
    Schneider, MR
    CLINICAL CANCER RESEARCH, 1998, 4 (05) : 1331 - 1336
  • [45] Simultaneous Chromophobe renal cell carcinoma and squamous renal cell carcinoma
    Rafael Fúnez
    Teresa Pereda
    Isabel Rodrigo
    Luis Robles
    Carlos González
    Diagnostic Pathology, 2
  • [46] Simultaneous Chromophobe renal cell carcinoma and squamous renal cell carcinoma
    Funez, Rafael
    Pereda, Teresa
    Rodrigo, Isabel
    Robles, Luis
    Gonzalez, Carlos
    DIAGNOSTIC PATHOLOGY, 2007, 2 (1)
  • [47] Preclinical evaluation of an unconventional ruthenium-gold-based chemotherapeutic: RANCE-1, in clear cell renal cell carcinoma
    Elie, Benelita T.
    Hubbard, Karen
    Pechenyy, Yuriy
    Layek, Buddhadev
    Prabha, Swayam
    Contel, Maria
    CANCER MEDICINE, 2019, 8 (09): : 4304 - 4314
  • [48] Renal cell carcinoma with vena cava involvement. Operative strategies and results
    Staehler, G
    Brkovic, D
    UROLOGE-AUSGABE A, 1997, 36 (02): : 109 - 116
  • [49] Molecular targeting agents in renal cell carcinoma: Present strategies and future perspectives
    Bjelogrlic, Snezana K.
    Radulovic, Sinisa
    Babovic, Nada
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (11) : 1058 - 1077
  • [50] New Strategies in Renal Cell Carcinoma: Targeting the Genetic and Metabolic Basis of Disease
    Srinivasan, Ramaprasad
    Ricketts, Christopher J.
    Sourbier, Carole
    Linehan, W. Marston
    CLINICAL CANCER RESEARCH, 2015, 21 (01) : 10 - 17
12345